Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 1
1964 2
1965 1
1966 3
1967 3
1968 4
1970 4
1971 7
1972 2
1973 2
1974 3
1975 2
1976 2
1977 10
1978 10
1979 7
1980 11
1981 15
1982 18
1983 23
1984 29
1985 23
1986 29
1987 44
1988 50
1989 47
1990 43
1991 52
1992 56
1993 75
1994 69
1995 75
1996 96
1997 126
1998 147
1999 225
2000 275
2001 281
2002 335
2003 357
2004 439
2005 482
2006 563
2007 648
2008 713
2009 828
2010 986
2011 1254
2012 1365
2013 1412
2014 1490
2015 1612
2016 1503
2017 1593
2018 1605
2019 1677
2020 1910
2021 2008
2022 1769
2023 1723
2024 1415

Text availability

Article attribute

Article type

Publication date

Search Results

26,385 results

Results by year

Filters applied: . Clear all
Page 1
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Rugo HS, Lerebours F, Ciruelos E, Drullinsky P, Ruiz-Borrego M, Neven P, Park YH, Prat A, Bachelot T, Juric D, Turner N, Sophos N, Zarate JP, Arce C, Shen YM, Turner S, Kanakamedala H, Hsu WC, Chia S. Rugo HS, et al. Among authors: park yh. Lancet Oncol. 2021 Apr;22(4):489-498. doi: 10.1016/S1470-2045(21)00034-6. Lancet Oncol. 2021. PMID: 33794206 Clinical Trial.
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, McArthur H, Pusztai L, Kümmel S, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Im SA, Untch M, Fasching PA, Mouret-Reynier MA, Foukakis T, Ferreira M, Cardoso F, Zhou X, Karantza V, Tryfonidis K, Aktan G, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. Among authors: park yh. N Engl J Med. 2024 Sep 15. doi: 10.1056/NEJMoa2409932. Online ahead of print. N Engl J Med. 2024. PMID: 39282906
Hepatocellular adenomas: recent updates.
Kim H, Park YN. Kim H, et al. Among authors: park yn. J Pathol Transl Med. 2021 May;55(3):171-180. doi: 10.4132/jptm.2021.02.27. Epub 2021 Apr 7. J Pathol Transl Med. 2021. PMID: 33823565 Free PMC article. Review.
Integrins in synapse regulation.
Park YK, Goda Y. Park YK, et al. Nat Rev Neurosci. 2016 Dec;17(12):745-756. doi: 10.1038/nrn.2016.138. Epub 2016 Nov 4. Nat Rev Neurosci. 2016. PMID: 27811927 Review.
An autoimmune transcriptional circuit drives FOXP3+ regulatory T cell dysfunction.
Sumida TS, Lincoln MR, He L, Park Y, Ota M, Oguchi A, Son R, Yi A, Stillwell HA, Leissa GA, Fujio K, Murakawa Y, Kulminski AM, Epstein CB, Bernstein BE, Kellis M, Hafler DA. Sumida TS, et al. Among authors: park y. Sci Transl Med. 2024 Aug 28;16(762):eadp1720. doi: 10.1126/scitranslmed.adp1720. Epub 2024 Aug 28. Sci Transl Med. 2024. PMID: 39196959
Structural basis for broad coronavirus neutralization.
Sauer MM, Tortorici MA, Park YJ, Walls AC, Homad L, Acton OJ, Bowen JE, Wang C, Xiong X, de van der Schueren W, Quispe J, Hoffstrom BG, Bosch BJ, McGuire AT, Veesler D. Sauer MM, et al. Among authors: park yj. Nat Struct Mol Biol. 2021 Jun;28(6):478-486. doi: 10.1038/s41594-021-00596-4. Epub 2021 May 12. Nat Struct Mol Biol. 2021. PMID: 33981021
Neoadjuvant pembrolizumab+chemotherapy/adjuvant pembrolizumab for Early-Stage Triple-Negative breast cancer: Quality-of-Life results from randomized KEYNOTE-522 study.
Dent R, Cortés J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Untch M, Fasching PA, Cardoso F, Haiderali A, Jia L, Nguyen AM, Pan W, O'Shaughnessy J, Schmid P. Dent R, et al. Among authors: park yh. J Natl Cancer Inst. 2024 Jun 24:djae129. doi: 10.1093/jnci/djae129. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38913881
26,385 results
You have reached the last available page of results. Please see the User Guide for more information.